CoChat

Regional Precuneus Cortical Hyperexcitability in Alzheimer's Disease Patients

Open access
Casula, Elias P., Borghi, Ilaria, Maiella, Michele, Pellicciari, Maria C., Bonnì, Sonia, Mencarelli, Lucia, Assogna, Martina, D'Acunto, Alessia, Di Lorenzo, Francesco, Spampinato, Danny A., Santarnecchi, Emiliano, Martorana, Alessandro, Koch, Giacomo · 2023 · Annals of Neurology
Cited by 66

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Objective: Neuronal excitation/inhibition (E/I) imbalance is a potential cause of neuronal network malfunctioning in Alzheimer's disease (AD), contributing to cognitive dysfunction. Here, we used a novel approach combining transcranial magnetic stimulation (TMS) and electroencephalography (EEG) to probe cortical excitability in different brain areas known to be directly involved in AD pathology. Methods: We performed TMS‐EEG recordings targeting the left dorsolateral prefrontal cortex (l‐DLPFC), the left posterior parietal cortex (l‐PPC), and the precuneus (PC) in a large sample of patients with mild‐to‐moderate AD (n = 65) that were compared with a group of age‐matched healthy controls (n = 21). Results: We found that patients with AD are characterized by a regional cortical hyperexcitability in the PC and, to some extent, in the frontal lobe, as measured by TMS‐evoked potentials. Notably, cortical excitability assessed over the l‐PPC was comparable between the 2 groups. Furthermore, we found that the individual level of PC excitability was associated with the level of cognitive impairment, as measured with Mini‐Mental State Examination, and with corticospinal fluid levels of Aβ 42. Interpretation: Our data provide novel evidence that precuneus cortical hyperexcitability is a key feature of synaptic dysfunction in patients with AD. The current results point to the combined approach of TMS and EEG as a novel promising technique to measure hyperexcitability in patients with AD. This index could represent a useful biomarker to stage disease severity and evaluate response to novel therapies. ANN NEUROL 2023;93:371–383

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.26514

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 66

Metadata

Authors
Casula, E. P., Borghi, I., Maiella, M., Pellicciari, M. C., Bonnì, S., Mencarelli, L., Assogna, M., D'Acunto, A., Di Lorenzo, F., Spampinato, D. A., Santarnecchi, E., Martorana, A., & Koch, G.
Venue
Annals of Neurology
Publisher
Wiley
Published
2022-10-18
Volume
93
Issue
2
Pages
371-383
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W4296619938
Cited by
66
References
19
FWCI
3.70
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Regional Precuneus Cortical Hyperexcitability in Alzheimer's Disease Patients. https://app.cochat.ai/papers/10.1002/ana.26514
The paper
Casula, E. P., Borghi, I., Maiella, M., Pellicciari, M. C., Bonnì, S., Mencarelli, L., Assogna, M., D'Acunto, A., Di Lorenzo, F., Spampinato, D. A., Santarnecchi, E., Martorana, A., & Koch, G. (2023). Regional Precuneus Cortical Hyperexcitability in Alzheimer's Disease Patients. Annals of Neurology. https://doi.org/10.1002/ana.26514

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.